Evaluation of the diagnostic value of YiDiXie <sup>™</sup> -SS, YiDiXie <sup>™</sup> -HS and YiDiXie <sup>™</sup> -D in prostate cancer
2024 · medRxiv · 0 citations
https://doi.org/10.1101/2024.06.26.24309554
H
Huimei Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
20
Citations
3
h-index
1
i10-index
Huimei Zhou is an academic researcher from Anhui Medical University. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & Bladder and Urothelial Cancer Treatments. The author has an h-index of 3, co-authored 15 publications.
Papers by this author
worksEvaluation of the diagnostic value of YiDiXie™-SS, YiDiXie™-HS and YiDiXie™-D in liver cancer
2024 · medRxiv · 0 citations
https://doi.org/10.1101/2024.07.15.24310471
Evaluation of the diagnostic value of YiDiXie™-SS, YiDiXie™-HS and YiDiXie™-D in colorectal cancer
2024 · medRxiv · 0 citations
https://doi.org/10.1101/2024.08.20.24312286
A three-miRNA panel in serum: Serving as a novel diagnostic method for nasopharyngeal carcinoma
2025 · The International Journal of Biological Markers · 0 citations
https://doi.org/10.1177/03936155251329041
A panel of three serum microRNAs as a potential diagnostic biomarker for renal cell carcinoma
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-01225-6
Potential biomarker for screening nasopharyngeal carcinoma: three-microRNA panel in serum
2025 · Translational Cancer Research · 0 citations
https://doi.org/10.21037/tcr-2024-2213
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat